The newest case is the fifth to bring similar allegations against Moderna in the same court, with three others, all filed Nov ...

Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

Novavax, Inc., based in Gaithersburg, Maryland, is a global biotechnology company focused on developing and commercializing innovative protein-based vaccines to combat serious infectious diseases, ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

HONG KONG SAR - Media OutReach Newswire - 30 October 2024 - AIM Vaccine (06660.HK), the leader in Chinese mRNA vaccines, announced on 30 th October that mRNA respiratory syncytial virus (RSV) vaccine ...

But which ones should you get? This year marks the second season for the new respiratory syncytial virus vaccine (RSV) for grown-ups. While not everyone needs it, the evidence so far suggests that ...

AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update. AIM Vaccine Co., Ltd. has secured clinical trial approval for its mRNA-based RSV vaccine, developed by its subsidiary Liverna ...

2 strain, prompting the approval of updated versions of the Pfizer and Moderna vaccines targeting that particular strain, and the Novavax vaccine ... for the flu and RSV. For people interested ...